Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Non-cash Items (2020 - 2025)

Treace Medical Concepts (TMCI) has disclosed Non-cash Items for 6 consecutive years, with $4.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-cash Items fell 74.73% year-over-year to $4.1 million, compared with a TTM value of $4.1 million through Dec 2025, down 74.73%, and an annual FY2025 reading of $4.1 million, down 74.73% over the prior year.
  • Non-cash Items was $4.1 million for Q4 2025 at Treace Medical Concepts, down from $16.2 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $38.4 million in Q4 2023 and bottomed at $3.7 million in Q4 2021.
  • Average Non-cash Items over 5 years is $11.6 million, with a median of $4.9 million recorded in 2021.
  • The sharpest move saw Non-cash Items surged 930.1% in 2023, then tumbled 74.73% in 2025.
  • Year by year, Non-cash Items stood at $3.7 million in 2021, then rose by 0.03% to $3.7 million in 2022, then soared by 930.1% to $38.4 million in 2023, then plummeted by 57.76% to $16.2 million in 2024, then crashed by 74.73% to $4.1 million in 2025.
  • Business Quant data shows Non-cash Items for TMCI at $4.1 million in Q4 2025, $16.2 million in Q4 2024, and $38.4 million in Q4 2023.